FDA Approves Med-El Cochlear Implant for Children 7 Months and Older
The FDA has approved an expanded indication for Med-El cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
The FDA has approved an expanded indication for Med-El cochlear implants for children seven months and older with bilateral sensorineural hearing loss.
As the fund’s inaugural supporter, Starkey will help UNICEF deliver early screening, assistive technology, and broader disability support to children worldwide.
Tricare provides hearing aid coverage for eligible children of retired service members, enhancing access to essential auditory care.
The clinical innovation lab is improving the use of 3D printing for custom pediatric hearing aid earmolds to significantly improve efficiency in patient care.
Read MoreUnitedHealthcare has expanded its coverage of cochlear implants to include children as young as 6 months effective Sept. 1, 2024.
Read MoreThe International Pediatric Conference, to be held this October 2024, will bring together global experts to discuss childhood hearing loss.
Read MoreThe ADHS and the Arizona Commission for the Deaf and the Hard of Hearing received a grant to enhance early pediatric hearing screening.
Read MoreThe plan aims to enhance access to pediatric audiology and Listening and Spoken Language services for children who are deaf or hard of hearing.
Read MoreThe HEAR program is a text messaging service supporting families of children with hearing loss through expert advice and community connection.
Read MoreWhile it’s not surprising to spot teens wearing headphones and earbuds, it’s also becoming a widespread trend among younger children, a national poll suggests.
Read MoreA look at advancements in pediatric hearing aids and advice to enhance the fitting experience for younger patients and their HCPs.
Read MoreThe clinical trial will test a gene therapy drug to treat children with a form of hereditary deafness caused by mutations in the OTOF gene.
Read MoreResearchers found the novel gene therapy to be an effective treatment for patients with a specific form of autosomal recessive deafness.
Read MoreTemporary hearing loss from ear infections can lead to deficits in auditory processing and language development in children years later.
Read MoreAccording to the legislation, coverage includes one hearing aid per ear, up to a cost of $1,500, every 24 months.
Read MoreAcclarent received FDA clearance for its pediatric Eustachian Tube Balloon Dilation System in the treatment of children.
Read MoreThe ACLU of Delaware alleges current practices violate the Americans with Disabilities Act and Section 504 of the Rehabilitation Act.
Read MoreThe Idaho Hearing Education and Aural Rehabilitation program is using funds to train, provide tuition, and financial support to 42 scholars.
Read More